The FDA said it received multiple reports that the baby formula is still being found on store shelves in multiple states.
The FDA says eight more infants have been hospitalized in the outbreak, warning that recalled ByHeart formula is still ...
The approval is for Eylea to treat macular edema following retinal vein occlusion with up to every eight-week dosing after an initial dosing period. The FDA also approved a monthly dosing option for ...
INSYTE marks the first FDA-approved clinical trial of an intravascular optical imaging system designed specifically for the neurovasculature. The Spryte nOCT Imaging System uses high-resolution ...
Amgen's Imdelltra received full approval from the Food and Drug Administration for use in patients with lung cancer. The biotechnology company said Wednesday Imdelltra received approval for adult ...
Nuvalent filed a new drug application for an experimental non-small cell lung cancer treatment with the Food and Drug Administration.
Dialectic Therapeutics Announces Dosing of First Patient in Platinum-Resistant Ovarian Cancer (PROC)
Dr. Stover's trial builds on the Phase 1a clinical data and the preclinical results, generated by Dialectic and Harvard School of Public Health, which demonstrate complete tumor eradication in both in ...
The Cancer Check blood test screens for more than 200 types of solid tumor cancers and has detected cancer before symptoms appear, as early as Stage 0, when there is a 99% survival rate. The addition ...
The Brisbane Cancer Conference is a premier oncology meeting that brings together leading international researchers, clinicians and industry experts working in the fields of translational oncology, ...
Ossium Health, a bioengineering company dedicated to improving human health through its organ donor bone marrow banking platform, announced today that Dr. Susannah Cantrell, PhD, has joined its ...
Beacon Biosignals, a leading neurotechnology company powering AI-driven neurodiagnostics and precision medicines for the brain, today announced a multi-year expansion of its strategic collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results